NCT01281735 International Chronic Myeloid Leukemia Pediatric Study
| NCT ID | NCT01281735 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Poitiers University Hospital |
| Condition | Chronic Myeloid Leukemia |
| Study Type | OBSERVATIONAL |
| Enrollment | 750 participants |
| Start Date | 2011-01 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 750 participants in total. It began in 2011-01 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the study is to describe and characterize CML in a large pediatric cohort of patients.
Eligibility Criteria
Inclusion Criteria: * patients less than 18 years of age * diagnosed Philadelphia positive and/or BCR-ABL positive Chronic Myeloid Leukemia (CML) all phases Exclusion Criteria: * patients more than 18 years of age at diagnosis of CML
Contact & Investigator
Frederic MILLOT, MD
PRINCIPAL INVESTIGATOR
Poitiers University Hospital
Frequently Asked Questions
Who can join the NCT01281735 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Chronic Myeloid Leukemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01281735 currently recruiting?
Yes, NCT01281735 is actively recruiting participants. Contact the research team at f.millot@chu-poitiers.fr for enrollment information.
Where is the NCT01281735 trial being conducted?
This trial is being conducted at North Adelaide, Australia, Vienna, Austria, Minsk, Belarus, Ghent, Belgium and 11 additional locations.
Who is sponsoring the NCT01281735 clinical trial?
NCT01281735 is sponsored by Poitiers University Hospital. The principal investigator is Frederic MILLOT, MD at Poitiers University Hospital. The trial plans to enroll 750 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.